VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 102 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $14,346,000 | -29.0% | 16,302,596 | 0.0% | 0.74% | +26.2% |
| Q1 2022 | $20,215,000 | -36.4% | 16,302,596 | 0.0% | 0.58% | -9.0% |
| Q4 2021 | $31,790,000 | -28.8% | 16,302,596 | 0.0% | 0.64% | +20.9% |
| Q3 2021 | $44,669,000 | -13.0% | 16,302,596 | 0.0% | 0.53% | -20.6% |
| Q2 2021 | $51,353,000 | +47.9% | 16,302,596 | 0.0% | 0.67% | -14.1% |
| Q1 2021 | $34,725,000 | +91.2% | 16,302,596 | +74.2% | 0.78% | +62.6% |
| Q4 2020 | $18,158,000 | – | 9,360,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|